Cargando…

Optimized mobilization of MHC class I- and II- restricted immunity by dendritic cell vaccine potentiates cancer therapy

Background: The participation of major histocompatibility complex (MHC) in antigen presentation shapes both the breadth and magnitude of specific T cell response. Dendritic cells (DCs) activated with nucleic acid or protein that encodes/incorporates multiple antigenic epitopes elicit MHC class I- an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Yingying, Liu, Yu, Huang, Jiaxin, Luo, Zhenyu, Guo, Xuemeng, Jiang, Mengshi, Li, Xiang, Lu, Yichao, Liu, Xu, Shan, Xinyu, Luo, Lihua, You, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065178/ https://www.ncbi.nlm.nih.gov/pubmed/35547749 http://dx.doi.org/10.7150/thno.71760

Ejemplares similares

Macropinocytosis in phagocytes: regulation of MHC class-II-restricted antigen presentation in dendritic cells
por: Liu, Zhenzhen, et al.
Publicado: (2015)

MHC class II–restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell–mediated autoimmunity
por: Irla, Magali, et al.
Publicado: (2010)

Thymus dictates major histocompatibility complex (MHC) specificity and immune response gene phenotype of class II MHC-restricted T cells but not of class I MHC-restricted T cells
Publicado: (1984)

Class II MHC–independent suppressive adhesion of dendritic cells by regulatory T cells in vivo
por: Yan, Jiacong, et al.
Publicado: (2017)

Identical peptides recognized by MHC class I- and II-restricted T cells
Publicado: (1989)

Influence of DM-sensitivity on immunogenicity of MHC class II restricted antigens
por: Bernhardt, Anna Luise, et al.
Publicado: (2021)

Dual-binding nanoparticles improve the killing effect of T cells on solid tumor
por: Luo, Zhenyu, et al.
Publicado: (2022)

Analyses of the TCR repertoire of MHC class II-restricted innate CD4(+) T cells
por: Kang, Byung Hyun, et al.
Publicado: (2015)

Appropriate Delivery of the CRISPR/Cas9 System through the Nonlysosomal Route: Application for Therapeutic Gene Editing
por: Yin, Hang, et al.
Publicado: (2020)

Cathepsin S Controls the Trafficking and Maturation of Mhc Class II Molecules in Dendritic Cells
por: Driessen, Christoph, et al.
Publicado: (1999)

MHC Class II Restricted Innate-Like Double Negative T Cells Contribute to Optimal Primary and Secondary Immunity to Leishmania major
por: Mou, Zhirong, et al.
Publicado: (2014)

MHC Class II Expression Restricted to CD8α(+) and CD11b(+) Dendritic Cells Is Sufficient for Control of Leishmania major
por: Lemos, Maria P., et al.
Publicado: (2004)

Inhibition of MHC class II-restricted T cell response by Lyt-2 alloantigen
Publicado: (1989)

Toward a Network Model of MHC Class II-Restricted Antigen Processing
por: Miller, Michael A., et al.
Publicado: (2013)

Presentation of Exogenous Antigens on Major Histocompatibility Complex (MHC) Class I and MHC Class II Molecules Is Differentially Regulated during Dendritic Cell Maturation
por: Delamarre, Lélia, et al.
Publicado: (2003)

High-throughput identification and dendritic cell-based functional validation of MHC class I-restricted Mycobacterium tuberculosis epitopes
por: Nair, Smita K., et al.
Publicado: (2014)

The impact of DM on MHC class II–restricted antigen presentation can be altered by manipulation of MHC–peptide kinetic stability
por: Lazarski, Christopher A., et al.
Publicado: (2006)

Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells
por: Kleijmeer, Monique, et al.
Publicado: (2001)

Predicting T cell recognition of MHC class I restricted neoepitopes
por: Koşaloğlu-Yalçın, Zeynep, et al.
Publicado: (2018)

Structural Properties of MHC Class II Ligands, Implications for the Prediction of MHC Class II Epitopes
por: Jørgensen, Kasper Winther, et al.
Publicado: (2010)

Draining Lymph Nodes of Corneal Transplant Hosts Exhibit Evidence for Donor Major Histocompatibility Complex (MHC) Class II–positive Dendritic Cells Derived from MHC Class II–negative Grafts
por: Liu, Ying, et al.
Publicado: (2002)

Direct Activation of Human Dendritic Cells by Particle-Bound but Not Soluble MHC Class II Ligand
por: Baleeiro, Renato B., et al.
Publicado: (2013)

Ligation of MHC Class II Induces PKC-Dependent Clathrin-Mediated Endocytosis of MHC Class II
por: Masaki, Kento, et al.
Publicado: (2020)

Oxygen nanocarrier broke the hypoxia trap of solid tumors and rescued transfection efficiency for gene therapy
por: Qin, Bing, et al.
Publicado: (2021)

Differences in antigen presentation to MHC class I-and class II- restricted influenza virus-specific cytolytic T lymphocyte clones
Publicado: (1986)

MHC-restricted minimal regulatory circuit initiated by a class II- autoreactive T cell clone
Publicado: (1987)

GILT: Shaping the MHC Class II-Restricted Peptidome and CD4(+) T Cell-Mediated Immunity
por: Hastings, Karen Taraszka
Publicado: (2013)

Characterization of a library of 20 HBV-specific MHC class II-restricted T cell receptors
por: Schreiber, Sophia, et al.
Publicado: (2021)

Superantigen and class II MHC molecules.
por: Kim, J.
Publicado: (1995)

Organizing MHC Class II Presentation
por: Fooksman, David R.
Publicado: (2014)

MHC Class II Presentation in Autoimmunity
por: Ishina, Irina A., et al.
Publicado: (2023)

HLA-DO as the Optimizer of Epitope Selection for MHC Class II Antigen Presentation
por: Poluektov, Yuri O., et al.
Publicado: (2013)

MHC2SKpan: a novel kernel based approach for pan-specific MHC class II peptide binding prediction
por: Guo, Linyuan, et al.
Publicado: (2013)

Role of PU.1 in MHC Class II Expression via CIITA Transcription in Plasmacytoid Dendritic Cells
por: Miura, Ryosuke, et al.
Publicado: (2016)

T regulatory cells mediate specific suppression by depleting peptide-MHC class II from dendritic cells
por: Akkaya, Billur, et al.
Publicado: (2019)

Regulating immune memory and reversing tumor thermotolerance through a step-by-step starving-photothermal therapy
por: Luo, Lihua, et al.
Publicado: (2021)

Characterization of Antigenic MHC-Class-I-Restricted T Cell Epitopes in the Glycoprotein of Ebolavirus
por: Powlson, Jonathan, et al.
Publicado: (2019)

Vanilloid Receptor 1 Agonists, Capsaicin and Resiniferatoxin, Enhance MHC Class I-restricted Viral Antigen Presentation in Virus-infected Dendritic Cells
por: Lee, Young-Hee, et al.
Publicado: (2016)

Cyclooxygenase Inhibitors, Aspirin and Ibuprofen, Inhibit MHC-restricted Antigen Presentation in Dendritic Cells
por: Kim, Hyun-Jin, et al.
Publicado: (2010)

Human Neonatal Dendritic Cells Are Competent in MHC Class I Antigen Processing and Presentation
por: Gold, Marielle C., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_uihqnr877iljsmhcd3265ac3e9